The role of exosomal long non-coding RNAs in cancer drug resistance

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Drug resistance is a major challenge in oncology, leading to relapse and reduced patient survival.
• The tumor microenvironment and cellular communication are crucial for overcoming drug resistance.
• Exosomes, small extracellular vesicles, mediate crosstalk between tumor and stroma cells, delivering functional molecules like long non-coding RNAs (lncRNAs).

Purpose of the Study:

• To explore the role of exosomal long non-coding RNAs (lncRNAs) in mediating cancer drug resistance.
• To highlight the potential of exosomal lncRNAs as biomarkers for tumor liquid biopsy.
• To understand the molecular mechanisms underlying exosomal lncRNA-induced pharmacologic resistance.

Main Methods:

• Literature review and analysis of existing research on exosomes, lncRNAs, and cancer drug resistance.
• Identification of key molecular players and pathways involved in exosomal lncRNA function.
• Examination of the impact of exosomal lncRNAs on various cancer treatment modalities.

Main Results:

• Exosomal lncRNAs are stable, found in body fluids, and implicated in promoting angiogenesis, cell proliferation, and drug resistance.
• These molecules influence the efficacy of chemotherapy, targeted therapy, hormone therapy, and immunotherapy.
• Exosomal lncRNAs are deregulated in cancer and represent potential biomarkers for early detection and monitoring.

Conclusions:

• Exosomal lncRNAs play a significant role in the development and progression of cancer drug resistance.
• Targeting exosomal lncRNAs or utilizing them as biomarkers holds promise for improving cancer therapy outcomes.
• Further research into the molecular mechanisms of exosomal lncRNAs can guide the development of novel anti-cancer drugs and resistance biomarkers.